D
Dominique Vince-Ranchère
Publications - 3
Citations - 472
Dominique Vince-Ranchère is an academic researcher. The author has contributed to research in topics: Sarcoma & Gene. The author has an hindex of 3, co-authored 3 publications receiving 398 citations.
Papers
More filters
Journal ArticleDOI
Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity
Frédéric Chibon,Pauline Lagarde,Sébastien Salas,Gaëlle Pérot,Véronique Brouste,Franck Tirode,Carlo Lucchesi,Aurélien de Reyniès,Audrey Kauffmann,Binh Bui,Philippe Terrier,Sylvie Bonvalot,Axel Le Cesne,Dominique Vince-Ranchère,Jean-Yves Blay,F. Collin,Louis Guillou,Agnès Leroux,Jean-Michel Coindre,Alain Aurias +19 more
TL;DR: A prognostic gene expression signature, complexity index in sarcomas (CINSARC), composed of 67 genes related to mitosis and chromosome management, is established, which predicts metastasis outcome and predicts outcome for gastrointestinal stromal tumors, breast carcinomas and lymphomas.
Journal ArticleDOI
RNA sequencing validation of the Complexity INdex in SARComas prognostic signature.
Tom Lesluyes,Gaëlle Pérot,Marine Roxane Largeau,Céline Brulard,Pauline Lagarde,Valérie Dapremont,Carlo Lucchesi,Agnès Neuville,Philippe Terrier,Dominique Vince-Ranchère,Maria Mendez-Lago,Marta Gut,Ivo Gut,Jean-Michel Coindre,Frédéric Chibon +14 more
TL;DR: These results demonstrate that CINSARC is a platform and material independent prognostic signature for metastatic outcome in various sarcomas and opens access to metastatic prognostication through NGS analysis on both frozen and FFPE tumours via the C INSARC signature.
Journal ArticleDOI
Recurrent TRIO Fusion in Nontranslocation-Related Sarcomas.
Lucile Delespaul,Lucile Delespaul,Tom Lesluyes,Tom Lesluyes,Gaëlle Pérot,Céline Brulard,Lydia Lartigue,Lydia Lartigue,Jessica Baud,Jessica Baud,Pauline Lagarde,Sophie Le Guellec,Agnès Neuville,Philippe Terrier,Dominique Vince-Ranchère,Susanne Schmidt,Anne Debant,Jean-Michel Coindre,Jean-Michel Coindre,Frédéric Chibon +19 more
TL;DR: TRO fusions have been identified in four different sarcoma histotypes, likely meaning that they are not related to a primary oncogenic event but rather to a secondary one implicated in tumor progression, as no such rearrangement was identified in sarcomas with simple genetics.